Thomas Eisenhart

Thomas Eisenhart joined ITB-MED as of April 2024 and has over 15 years of experience working in the Life Sciences industry. Prior to joining ITB-MED, Thomas served his last 10 years at ICON plc in roles of increasing responsibility. His previous role during his tenure with ICON plc included a Grants and Contract Coordinator at Amgen, where he handled all the site payments, as well as some procurement. His next role was Financial Planning and Analysis Manager where he handled all the global forecasting and budgeting across several therapeutic areas (cardiovascular disease, hematology, oncology, and woman’s healthcare). Most recently before joining ITB-MED, Thomas worked as a Contract and Grants Manager at Vertex where he negotiated site contracts and budgets for diabetes, kidney disease, and rare disease. Earlier in his career, he worked as senior analyst for DrugDev (an IQVIA company) and staff accountant at Touchpoint Solutions (Pharmaceutical Manufacturing company). Thomas graduated from Temple University’s Fox School of Business with a degree in Finance.